APO Research
Talk to an analyst

APO RESEARCH · REPORT

Panic Attack Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Panic Attack Treatment Market Analysis and Forecast 2026-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchPanic Attack Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Panic Attack Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Panic Attack Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Panic Attack Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Panic Attack Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Panic Attack Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Panic Attack Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Panic Attack Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Panic Attack Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Panic Attack Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Panic Attack Treatment include Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Actavis Generics, Bristol Myers Squibb(BMS), Baxter International Inc., Sumitomo Dainippon Pharma, GlaxoSmithKline plc., Pfizer,Inc. and Eli Lilly and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Panic Attack Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Panic Attack Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Panic Attack Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Panic Attack Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Panic Attack Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Panic Attack Treatment revenue, projected growth trends, production technology, application and end-user industry.

Panic Attack Treatment Segment by Company

Noven Pharmaceuticals, Inc.

Recordati Rare Diseases(Recordati)

Actavis Generics

Bristol Myers Squibb(BMS)

Baxter International Inc.

Sumitomo Dainippon Pharma

GlaxoSmithKline plc.

Pfizer,Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Shionogi & Co., Ltd.

Panic Attack Treatment Segment by Type

Selective Serotonin Reuptake Inhibitor(SSRI)

Benzodiazepines(BZD)

Serotonin Norepinephrine Reuptake Inhibitor(SNRI)

Panic Attack Treatment Segment by Application

Hospitals

Mental Healthcare Centers

Others

Panic Attack Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Panic Attack Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Panic Attack Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Panic Attack Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Panic Attack Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Panic Attack Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Panic Attack Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Panic Attack Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Selective Serotonin Reuptake Inhibitor(SSRI) Major Player Table 3. Benzodiazepines(BZD) Major Player Table 4. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Major Player Table 5. Global Panic Attack Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Mental Healthcare Centers Major Player Table 8. Others Major Player Table 9. Panic Attack Treatment Industry Trends Table 10. Panic Attack Treatment Industry Drivers Table 11. Panic Attack Treatment Industry Opportunities and Challenges Table 12. Panic Attack Treatment Industry Restraints Table 13. Global Panic Attack Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Panic Attack Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Panic Attack Treatment Market Share by Region (2021-2026) Table 16. Global Panic Attack Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Panic Attack Treatment Market Share by Region (2027-2032) Table 18. Global Panic Attack Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Panic Attack Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Panic Attack Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Panic Attack Treatment Key Players Headquarters & Area Served Table 22. Global Panic Attack Treatment Players, Product Type & Application Table 23. Global Panic Attack Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Panic Attack Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Panic Attack Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Panic Attack Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Panic Attack Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Panic Attack Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Panic Attack Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Panic Attack Treatment Revenue Market Share by Application (2027-2032) Table 36. Noven Pharmaceuticals, Inc. Company Information Table 37. Noven Pharmaceuticals, Inc. Business Overview Table 38. Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio Table 40. Noven Pharmaceuticals, Inc. Recent Development Table 41. Recordati Rare Diseases(Recordati) Company Information Table 42. Recordati Rare Diseases(Recordati) Business Overview Table 43. Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio Table 45. Recordati Rare Diseases(Recordati) Recent Development Table 46. Actavis Generics Company Information Table 47. Actavis Generics Business Overview Table 48. Actavis Generics Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Actavis Generics Panic Attack Treatment Product Portfolio Table 50. Actavis Generics Recent Development Table 51. Bristol Myers Squibb(BMS) Company Information Table 52. Bristol Myers Squibb(BMS) Business Overview Table 53. Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio Table 55. Bristol Myers Squibb(BMS) Recent Development Table 56. Baxter International Inc. Company Information Table 57. Baxter International Inc. Business Overview Table 58. Baxter International Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Baxter International Inc. Panic Attack Treatment Product Portfolio Table 60. Baxter International Inc. Recent Development Table 61. Sumitomo Dainippon Pharma Company Information Table 62. Sumitomo Dainippon Pharma Business Overview Table 63. Sumitomo Dainippon Pharma Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio Table 65. Sumitomo Dainippon Pharma Recent Development Table 66. GlaxoSmithKline plc. Company Information Table 67. GlaxoSmithKline plc. Business Overview Table 68. GlaxoSmithKline plc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio Table 70. GlaxoSmithKline plc. Recent Development Table 71. Pfizer,Inc. Company Information Table 72. Pfizer,Inc. Business Overview Table 73. Pfizer,Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Pfizer,Inc. Panic Attack Treatment Product Portfolio Table 75. Pfizer,Inc. Recent Development Table 76. Eli Lilly and Company Company Information Table 77. Eli Lilly and Company Business Overview Table 78. Eli Lilly and Company Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Eli Lilly and Company Panic Attack Treatment Product Portfolio Table 80. Eli Lilly and Company Recent Development Table 81. F. Hoffmann-La Roche Ltd Company Information Table 82. F. Hoffmann-La Roche Ltd Business Overview Table 83. F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio Table 85. F. Hoffmann-La Roche Ltd Recent Development Table 86. Abbott Laboratories Company Information Table 87. Abbott Laboratories Business Overview Table 88. Abbott Laboratories Panic Attack Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Abbott Laboratories Panic Attack Treatment Product Portfolio Table 90. Abbott Laboratories Recent Development Table 91. Shionogi & Co., Ltd. Company Information Table 92. Shionogi & Co., Ltd. Business Overview Table 93. Shionogi & Co., Ltd. Panic Attack Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio Table 95. Shionogi & Co., Ltd. Recent Development Table 96. North America Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Panic Attack Treatment Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Panic Attack Treatment Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Panic Attack Treatment Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Panic Attack Treatment Revenue by Country (US$ Million) & (2027-2032) Table 110. China Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 111. China Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 112. China Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 113. China Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Panic Attack Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Panic Attack Treatment Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Panic Attack Treatment Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Panic Attack Treatment Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Panic Attack Treatment Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Panic Attack Treatment Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Panic Attack Treatment Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Panic Attack Treatment Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Panic Attack Treatment Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Panic Attack Treatment Image Figure 2. Global Panic Attack Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Panic Attack Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Selective Serotonin Reuptake Inhibitor(SSRI) Image Figure 5. Benzodiazepines(BZD) Image Figure 6. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Image Figure 7. Global Panic Attack Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Panic Attack Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Mental Healthcare Centers Image Figure 11. Others Image Figure 12. Global Panic Attack Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Panic Attack Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Panic Attack Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Panic Attack Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Panic Attack Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Panic Attack Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Panic Attack Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Panic Attack Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Panic Attack Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Panic Attack Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Panic Attack Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Panic Attack Treatment Revenue Share by Type (2021-2032) Figure 25. North America Panic Attack Treatment Revenue Share by Application (2021-2032) Figure 26. North America Panic Attack Treatment Revenue Share by Country (2021-2032) Figure 27. United States Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Panic Attack Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Panic Attack Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Panic Attack Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Panic Attack Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Panic Attack Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Panic Attack Treatment Revenue Share by Type (2021-2032) Figure 44. China Panic Attack Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Panic Attack Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Panic Attack Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Panic Attack Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Panic Attack Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Panic Attack Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Panic Attack Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Panic Attack Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Panic Attack Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Panic Attack Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Selective Serotonin Reuptake Inhibitor(SSRI)
  • Benzodiazepines(BZD)
  • Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Applications
  • Hospitals
  • Mental Healthcare Centers
  • Others
Companies covered
  • Noven Pharmaceuticals, Inc.
  • Recordati Rare Diseases(Recordati)
  • Actavis Generics
  • Bristol Myers Squibb(BMS)
  • Baxter International Inc.
  • Sumitomo Dainippon Pharma
  • GlaxoSmithKline plc.
  • Pfizer,Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Shionogi & Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Panic Attack Treatment Market by Type
  3. 1.2.1 Global Panic Attack Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Selective Serotonin Reuptake Inhibitor(SSRI)
  5. 1.2.3 Benzodiazepines(BZD)
  6. 1.2.4 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
  7. 1.3 Panic Attack Treatment Market by Application
  8. 1.3.1 Global Panic Attack Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Mental Healthcare Centers
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Panic Attack Treatment Market Dynamics
  1. 2.1 Panic Attack Treatment Industry Trends
  2. 2.2 Panic Attack Treatment Industry Drivers
  3. 2.3 Panic Attack Treatment Industry Opportunities and Challenges
  4. 2.4 Panic Attack Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Panic Attack Treatment Market Perspective (2021-2032)
  2. 3.2 Global Panic Attack Treatment Growth Trends by Region
  3. 3.2.1 Global Panic Attack Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Panic Attack Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Panic Attack Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Panic Attack Treatment Revenue by Players
  2. 4.1.1 Global Panic Attack Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Panic Attack Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Panic Attack Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Panic Attack Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Panic Attack Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Panic Attack Treatment Players, Product Type & Application
  8. 4.5 Global Panic Attack Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Panic Attack Treatment Market CR5 and HHI
  11. 4.6.3 2025 Panic Attack Treatment Tier 1, Tier 2, and Tier 3
5 Panic Attack Treatment Market Size by Type
  1. 5.1 Global Panic Attack Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Panic Attack Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Panic Attack Treatment Revenue Market Share by Type (2021-2032)
6 Panic Attack Treatment Market Size by Application
  1. 6.1 Global Panic Attack Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Panic Attack Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Panic Attack Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Noven Pharmaceuticals, Inc.
  2. 7.1.1 Noven Pharmaceuticals, Inc. Company Information
  3. 7.1.2 Noven Pharmaceuticals, Inc. Business Overview
  4. 7.1.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio
  6. 7.1.5 Noven Pharmaceuticals, Inc. Recent Developments
  7. 7.2 Recordati Rare Diseases(Recordati)
  8. 7.2.1 Recordati Rare Diseases(Recordati) Company Information
  9. 7.2.2 Recordati Rare Diseases(Recordati) Business Overview
  10. 7.2.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio
  12. 7.2.5 Recordati Rare Diseases(Recordati) Recent Developments
  13. 7.3 Actavis Generics
  14. 7.3.1 Actavis Generics Company Information
  15. 7.3.2 Actavis Generics Business Overview
  16. 7.3.3 Actavis Generics Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Actavis Generics Panic Attack Treatment Product Portfolio
  18. 7.3.5 Actavis Generics Recent Developments
  19. 7.4 Bristol Myers Squibb(BMS)
  20. 7.4.1 Bristol Myers Squibb(BMS) Company Information
  21. 7.4.2 Bristol Myers Squibb(BMS) Business Overview
  22. 7.4.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio
  24. 7.4.5 Bristol Myers Squibb(BMS) Recent Developments
  25. 7.5 Baxter International Inc.
  26. 7.5.1 Baxter International Inc. Company Information
  27. 7.5.2 Baxter International Inc. Business Overview
  28. 7.5.3 Baxter International Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Baxter International Inc. Panic Attack Treatment Product Portfolio
  30. 7.5.5 Baxter International Inc. Recent Developments
  31. 7.6 Sumitomo Dainippon Pharma
  32. 7.6.1 Sumitomo Dainippon Pharma Company Information
  33. 7.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 7.6.3 Sumitomo Dainippon Pharma Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio
  36. 7.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 7.7 GlaxoSmithKline plc.
  38. 7.7.1 GlaxoSmithKline plc. Company Information
  39. 7.7.2 GlaxoSmithKline plc. Business Overview
  40. 7.7.3 GlaxoSmithKline plc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio
  42. 7.7.5 GlaxoSmithKline plc. Recent Developments
  43. 7.8 Pfizer,Inc.
  44. 7.8.1 Pfizer,Inc. Company Information
  45. 7.8.2 Pfizer,Inc. Business Overview
  46. 7.8.3 Pfizer,Inc. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer,Inc. Panic Attack Treatment Product Portfolio
  48. 7.8.5 Pfizer,Inc. Recent Developments
  49. 7.9 Eli Lilly and Company
  50. 7.9.1 Eli Lilly and Company Company Information
  51. 7.9.2 Eli Lilly and Company Business Overview
  52. 7.9.3 Eli Lilly and Company Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Eli Lilly and Company Panic Attack Treatment Product Portfolio
  54. 7.9.5 Eli Lilly and Company Recent Developments
  55. 7.10 F. Hoffmann-La Roche Ltd
  56. 7.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 7.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 7.10.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio
  60. 7.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 7.11 Abbott Laboratories
  62. 7.11.1 Abbott Laboratories Company Information
  63. 7.11.2 Abbott Laboratories Business Overview
  64. 7.11.3 Abbott Laboratories Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abbott Laboratories Panic Attack Treatment Product Portfolio
  66. 7.11.5 Abbott Laboratories Recent Developments
  67. 7.12 Shionogi & Co., Ltd.
  68. 7.12.1 Shionogi & Co., Ltd. Company Information
  69. 7.12.2 Shionogi & Co., Ltd. Business Overview
  70. 7.12.3 Shionogi & Co., Ltd. Panic Attack Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio
  72. 7.12.5 Shionogi & Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Panic Attack Treatment Revenue (2021-2032)
  2. 8.2 North America Panic Attack Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Panic Attack Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Panic Attack Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Panic Attack Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Panic Attack Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Panic Attack Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Panic Attack Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Panic Attack Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Panic Attack Treatment Revenue by Country
  11. 8.6.1 North America Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Panic Attack Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Panic Attack Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Panic Attack Treatment Revenue (2021-2032)
  2. 9.2 Europe Panic Attack Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Panic Attack Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Panic Attack Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Panic Attack Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Panic Attack Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Panic Attack Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Panic Attack Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Panic Attack Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Panic Attack Treatment Revenue by Country
  11. 9.6.1 Europe Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Panic Attack Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Panic Attack Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Panic Attack Treatment Revenue (2021-2032)
  2. 10.2 China Panic Attack Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Panic Attack Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Panic Attack Treatment Revenue by Type (2027-2032)
  5. 10.3 China Panic Attack Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Panic Attack Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Panic Attack Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Panic Attack Treatment Revenue by Application (2027-2032)
  9. 10.5 China Panic Attack Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Panic Attack Treatment Revenue (2021-2032)
  2. 11.2 Asia Panic Attack Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Panic Attack Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Panic Attack Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Panic Attack Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Panic Attack Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Panic Attack Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Panic Attack Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Panic Attack Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Panic Attack Treatment Revenue by Country
  11. 11.6.1 Asia Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Panic Attack Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Panic Attack Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Panic Attack Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Panic Attack Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Panic Attack Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Panic Attack Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Panic Attack Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Panic Attack Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Panic Attack Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Panic Attack Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Panic Attack Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Panic Attack Treatment Revenue by Country
  11. 12.6.1 SAMEA Panic Attack Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Panic Attack Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Panic Attack Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst